Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway
Authors:
Preprint
Abstract
We previously discovered that deletion of c-Rel in the Eμ-Myc mouse model of lymphoma results in earlier onset of disease, a finding that contrasted with the expected function of this NF-κB subunit in B-cell malignancies. Here we report that c-rel -/- Eµ-Myc cells have an unexpected and major defect in the CHK1 pathway, with almost undetectable levels of CHK1 and CLSPN protein leading to therapeutic resistance to the highly specific CHK1 inhibitor (CHK1i) CCT244747. Similar downregulation of CHK1 levels was also seen in CCT244747 resistant U20S osteosarcoma cells. Further investigation revealed that downregulation of the deubiquitinase USP1 is responsible, at least in part, for these effects. Importantly, we demonstrate that c-rel -/- Eµ-Myc lymphoma cells survive though upregulation of compensatory PI3K/AKT pathway activity. Moreover, targeting this pathway with Pictilisib (GDC-0941) effectively killed c-rel -/- Eµ-Myc in vivo, while having no effect on wild type Eμ-Myc cells. This data reveals an NF-κB regulated pathway controlling CHK1 activity in cancer cells and identifies a potential mechanism for both acquiring and overcoming CHK1i resistance in cancer patients.Keywords
All Related Versions
- Published version: Biochemical Journal, 479 (19), 2063.
This publication has 63 references indexed in Scilit:
- DNA damage response inhibitors: Mechanisms and potential applications in cancer therapyCancer Treatment Reviews, 2017
- A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-κB-dependent liver regeneration and cancerOncogene, 2016
- Myc induced replicative stress response: How to cope with it and exploit itBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2015
- Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stressMolecular Oncology, 2014
- Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenanceCell Division, 2012
- The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migrationMolecular Biology of the Cell, 2011
- Anticancer therapy with checkpoint inhibitors: what, where and when?Trends in Pharmacological Sciences, 2011
- DNA replication stress, genome instability and agingNucleic Acids Research, 2007
- Cisplatin Mimics ARF Tumor Suppressor Regulation of RelA (p65) Nuclear Factor-κB TransactivationCancer Research, 2006
- p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor SuppressorMolecular Cell, 2003